🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single-arm, prospective clinical study to evaluate the efficacy a...
Status
Recruiting
Location
Second Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2025-03-11
Trial ID
NCT07022223
Treatments Being Tested
This multicenter, open-label, randomized controlled trial aims to evaluate ...
Status
Recruiting
Location
Ruijin Hospital
Start Date
2024-07-10
Trial ID
NCT06496308
Treatments Being Tested
This is a multicenter, open-label, single-arm, prospective clinical study o...
Status
Recruiting
Location
The First Affiliated Hospital with Nanjing Medical University
Start Date
2026-02-07
Trial ID
NCT07410520
Treatments Being Tested
B-cell non-Hodgkin's lymphoma (B-NHL) is the most common type of NHL. Altho...
Status
Unknown
Location
Shandong Provincial Hospital
Start Date
2021-04-15
Trial ID
NCT05097443
The purpose of this study is to evaluate the safety and efficacy of orelabr...
Status
Unknown
Location
The first affiliated hospital of bengbu medical college
Start Date
2022-11-02
Trial ID
NCT05234684
Treatments Being Tested
This is a single arm, single center, open label pilot study of Orelabrutini...
Status
Completed
Location
Department of Hematology, Huashan Hospital, Fudan University
Start Date
2021-10-10
Trial ID
NCT05036577
Treatments Being Tested
A multicenter, prospective, randomized, open-label, controlled trial to eva...
Status
Unknown
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Start Date
2022-06-01
Trial ID
NCT05351346
Treatments Being Tested
This study aims to compare the efficacy and safety of Polatuzumab Vedotin, ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-10-01
Trial ID
NCT06516978
This is a prospective, single-arm, open-label phase II clinical trial that ...
Status
Recruiting
Location
No. 197 Ruijin 2nd Road, Huangpu District, Shanghai
Start Date
2024-12-10
Trial ID
NCT06701357
Treatments Being Tested
Assess the preliminary efficacy and safety of orelabrutinib in combination ...
Status
Recruiting
Location
Second Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2025-05-05
Trial ID
NCT07078500
Treatments Being Tested